Physiology and Molecular Biology of Lung Water Transport

肺水运输的生理学和分子生物学

基本信息

  • 批准号:
    7245012
  • 负责人:
  • 金额:
    $ 32.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-01 至 2009-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The central focus of this proposal is to define the basic mechanisms of water/fluid transport in the lung and airways in health and disease, and to identify new targets for drug development. Aquaporins (AQPs) are water-transporting proteins expressed in lung microvasculature (AQP1), airways (AQP3 and AQP4), alveolar epithelium (AQP5) and submucosal gland epithelium (AQP5). In the initial award period, mice lacking each of the four major lung aquaporin water channels were generated and used to study the role of aquaporins in fluid transport in alveoli, large airways, and airway submucosal glands. An important finding - AQP5-dependent fluid secretion in airway submucosal glands - will be followed up in Aim 1. Novel aquaporin-selective inhibitors and model systems will be used to test the hypothesis that fluid secretion in human submucosal glands is regulated by AQP5 expression and function. Aim 2 will critically address the role of aquaporins in other aspects of lung physiology using inhibitors, mouse models, and human tissues. The hypothesis will be tested that lung/airway aquaporins facilitate fluid removal from the airspaces and lung parenchyma following clinically relevant disease/injury. In Aim 3, novel lung slice, cell culture and fluorescence methods will be used to define water and salt transporting mechanisms in distal airways, an important but under-studied epithelium. The hypothesis that AQP4 and CFTR are required for distal airway fluid absorption will be tested, and the role of the distal airway epithelium is lung fluid clearance will be determined. Together, these experiments will provide definitive information on the role of aquaporins in lung physiology and disease. A unique strength of our research program has been the introduction of new approaches to study lung physiology in vivo and in freshly harvested tissues, and the development of incisive biophysical tools (fluorescent probes, microscopy methods) and inhibitors for water and ion transport studies.
描述(由申请人提供):本提案的中心重点是确定健康和疾病中肺和气道中水/液体运输的基本机制,并确定药物开发的新靶点。水通道蛋白(AQPs)是在肺微血管(AQP1)、气道(AQP3和AQP4)、肺泡上皮(AQP5)和粘膜下腺上皮(AQP5)中表达的水转运蛋白。在初始奖励期,生成缺乏四种主要肺水通道的小鼠,并用于研究水通道蛋白在肺泡、大气道和气道粘膜下腺的液体运输中的作用。一个重要的发现-气道粘膜下腺aqp5依赖性液体分泌-将在Aim 1中随访。新型水通道蛋白选择性抑制剂和模型系统将用于验证人体粘膜下腺的液体分泌受AQP5表达和功能调节的假设。目的2将利用抑制剂、小鼠模型和人体组织,重点探讨水通道蛋白在肺生理学其他方面的作用。在临床相关疾病/损伤后,肺/气道水通道蛋白促进液体从空气和肺实质中清除的假设将得到验证。在Aim 3中,新的肺切片、细胞培养和荧光方法将用于定义远端气道中水和盐的运输机制,远端气道是一个重要但研究不足的上皮。验证远端气道液体吸收需要AQP4和CFTR的假设,确定远端气道上皮在肺液体清除中的作用。总之,这些实验将为水通道蛋白在肺部生理和疾病中的作用提供明确的信息。我们的研究项目的一个独特优势是引入了新的方法来研究体内和新鲜收获的组织中的肺生理,并开发了敏锐的生物物理工具(荧光探针,显微镜方法)和用于水和离子运输研究的抑制剂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALAN S VERKMAN其他文献

ALAN S VERKMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALAN S VERKMAN', 18)}}的其他基金

Urea transport inhibitors as a new class of diuretics
尿素转运抑制剂作为新型利尿剂
  • 批准号:
    9248354
  • 财政年份:
    2014
  • 资助金额:
    $ 32.32万
  • 项目类别:
Urea transport inhibitors as a new class of diuretics
尿素转运抑制剂作为新型利尿剂
  • 批准号:
    8666579
  • 财政年份:
    2014
  • 资助金额:
    $ 32.32万
  • 项目类别:
Urea transport inhibitors as a new class of diuretics
尿素转运抑制剂作为新型利尿剂
  • 批准号:
    8816096
  • 财政年份:
    2014
  • 资助金额:
    $ 32.32万
  • 项目类别:
Application of Novel Optical Methods to Cell Dynamics
新型光学方法在细胞动力学中的应用
  • 批准号:
    8451997
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Application of Novel Optical Methods to Cell Dynamics
新型光学方法在细胞动力学中的应用
  • 批准号:
    8642647
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Application of Novel Optical Methods to Cell Dynamics
新型光学方法在细胞动力学中的应用
  • 批准号:
    8210242
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Admin Core Verkman
管理核心沃克曼
  • 批准号:
    8564913
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Core A Verkman Screening Core
核心 A Verkman 筛选核心
  • 批准号:
    8564917
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Core C finkbeiner Cell Models Core
核心 C finkbeiner 细胞模型核心
  • 批准号:
    8564919
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:
Application of Novel Optical Methods to Cell Dynamics
新型光学方法在细胞动力学中的应用
  • 批准号:
    8827336
  • 财政年份:
    2012
  • 资助金额:
    $ 32.32万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.32万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了